Bellevue Group Ag Ultragenyx Pharmaceutical Inc. Transaction History

Bellevue Group Ag

$5.93 Billion
Q3 2024

A detailed history of Bellevue Group Ag transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 4,000 shares of RARE stock, worth $179,400. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,000

Previous 4,000 -0.0%

Holding current value

$179,400

Previous $164,000 35.37%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$37.42 - $51.61 $149,680 - $206,440	4,000 New	4,000 $164,000
Q2 2022 Aug 11, 2022	BUY	$45.8 - $85.4 $242,739 - $452,620	5,300 Added 20.62%	31,000 $1.85 Million
Q1 2022 May 13, 2022	BUY	$62.2 - $84.4 $292,340 - $396,680	4,700 Added 22.38%	25,700 $1.87 Million
Q4 2021 Feb 10, 2022	SELL	$73.71 - $87.86 $508,598 - $606,234	-6,900 Reduced 24.73%	21,000 $1.77 Million
Q3 2021 Nov 12, 2021	BUY	$77.92 - $102.4 $506,480 - $665,600	6,500 Added 30.37%	27,900 $2.52 Million
Q2 2021 Aug 12, 2021	SELL	$92.19 - $115.71 $1.81 Million - $2.27 Million	-19,600 Reduced 47.8%	21,400 $2.04 Million
Q3 2020 Nov 16, 2020	BUY	$72.98 - $90.0 $1.24 Million - $1.53 Million	17,000 Added 70.83%	41,000 $3.37 Million
Q2 2020 Aug 13, 2020	BUY	$46.91 - $78.22 $117,274 - $195,550	2,500 Added 11.63%	24,000 $1.88 Million
Q1 2020 May 14, 2020	BUY	$33.8 - $62.9 $726,699 - $1.35 Million	21,500 New	21,500 $955,000
Q3 2019 Nov 14, 2019	SELL	$42.5 - $63.11 $969,000 - $1.44 Million	-22,800 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$54.93 - $74.36 $384,510 - $520,520	-7,000 Reduced 23.49%	22,800 $1.45 Million
Q1 2019 May 15, 2019	BUY	$39.87 - $69.36 $303,012 - $527,136	7,600 Added 34.23%	29,800 $2.07 Million
Q4 2018 Feb 12, 2019	SELL	$38.89 - $77.3 $375,288 - $745,945	-9,650 Reduced 30.3%	22,200 $965,000
Q3 2018 Nov 13, 2018	SELL	$71.81 - $90.15 $524,213 - $658,095	-7,300 Reduced 18.65%	31,850 $2.43 Million
Q2 2018 Aug 07, 2018	SELL	$48.54 - $85.31 $55,821 - $98,106	-1,150 Reduced 2.85%	39,150 $3.01 Million
Q1 2018 May 09, 2018	SELL	$44.33 - $58.52 $26,598 - $35,112	-600 Reduced 1.47%	40,300 $2.06 Million
Q4 2017 Feb 14, 2018	SELL	$43.54 - $57.32 $47,894 - $63,052	-1,100 Reduced 2.62%	40,900 $1.9 Million
Q2 2017 Aug 14, 2017	BUY	N/A	42,000	42,000 $1.62 Million

Others Institutions Holding RARE

# of Institutions

325

Shares Held

85.5M

Call Options Held

520K

Put Options Held

406K

View Full List

About Ultragenyx Pharmaceutical Inc.

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.14B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

More about RARE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Ultragenyx Pharmaceutical Inc. Transaction History